| S-Trityl-L-cysteine | IC50 | 352.0 [1] |
| S-Trityl-L-cysteine | Ki | 107.3 [1] |
| Monastrol | IC50 | 7452.0 [1] |
| S-4-Methoxyltrityl-L-cysteine | IC50 | 28.5 [1], 166.0 [2], 270.0 [3] |
| S-4-Methoxyltrityl-L-cysteine | Ki | 9.1 [1], 15.7 [2], 21.6 [3], 50.0 [4], 200.0 [5] |
| N-(3-Aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxochromen-2-yl)-2-methylpropyl]-4-methylbenzamide | IC50 | 484.0 [1] |
| N-(3-Aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxochromen-2-yl)-2-methylpropyl]-4-methylbenzamide | Ki | 0.5 [1] |
| 2-(Tritylthio)ethanamine | IC50 | 241.2 [1], 395.61 [2] |
| 2-(Tritylthio)ethanamine | Ki | 150.0 [1], 152.3 [2], 156.1 [3], 245.0 [4], 245.5 [5] |
| N-(4-Acetyl-5-methyl-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide | IC50 | 1300.0 [1] |
| Ispinesib | IC50 | 1.2 [1], 5.0 [2], 47.0 [3] |
| Ispinesib | Ki | 2.3 [1], 2.5 [2] |
| N-[3-Fluoro-4'-(trifluoromethyl)-4-biphenylyl]urea | IC50 | 15.0 [1], 100.0 [2] |
| N-[3-Fluoro-4'-(trifluoromethyl)-4-biphenylyl]urea | Ki | 6.8 [1], 8.8 [2], 10.0 [3] |
| 6-[4-(Trifluoromethyl)phenyl]-3,4-dihydro-2(1H)-quinolinone | IC50 | 46.0 [1] |
| 6-[4-(Trifluoromethyl)phenyl]-3,4-dihydro-2(1H)-quinolinone | Ki | 1.4 [1], 1.8 [2], 2.2 [3], 66.0 [4] |
| Filanesib | IC50 | 6.0 [1], 18.0 [2] |
| Adociasulfate-2 | IC50 | 3500.0 [1], 5300.0 [2], 7300.0 [3], 13900.0 [4] |
| trans-HR22C16 | IC50 | 800.0 [1], 7100.0 [2] |
| (2R)-2-Amino-3-[(naphthalen-2-yldiphenylmethyl)sulfanyl]propanoic acid | IC50 | 16.3 [1] |
| (2R)-2-Amino-3-[(naphthalen-2-yldiphenylmethyl)sulfanyl]propanoic acid | Ki | 4.2 [1], 50.0 [2], 200.0 [3] |
| (2R)-2-Amino-3-{[(4-methylphenyl)diphenylmethyl]sulfanyl}propanoic acid | IC50 | 61.7 [1] |
| (2R)-2-Amino-3-{[(4-methylphenyl)diphenylmethyl]sulfanyl}propanoic acid | Ki | 13.6 [1], 50.0 [2], 100.0 [3] |
| [(4R)-4-(3-Hydroxyphenyl)-1,6-dimethyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-5-YL](phenyl)methanone | IC50 | 110.0 [1], 150.0 [2] |
| (S)-(4-(3-Hydroxyphenyl)-1,6-dimethyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(phenyl)methanone | IC50 | 150.0 [1], 520.0 [2], 650.0 [3] |
| 4-(3-Methylphenyl)-4,4-diphenylbutan-1-amine | Ki | 8.8 [1], 10.8 [2], 13.7 [3] |
| S-Trityl-D-Cysteine | IC50 | 306.2 [1], 1000.0 [2] |
| S-Trityl-D-Cysteine | Ki | 98.6 [1] |
| Terpendole E | IC50 | 23000.0 [1], 34700.0 [2] |
| N-[1-(3-Benzyl-7-chloro-4-oxoquinazolin-2-yl)propyl]-4-bromo-N-[3-(dimethylamino)propyl]benzamide | IC50 | 29.0 [1], 49.0 [2], 53.0 [3] |
| (R)-2-Amino-3-(diphenyl(4-(trifluoromethyl)phenyl)methylthio)propanoic acid | IC50 | 116.4 [1], 262.0 [2] |
| (R)-2-Amino-3-(diphenyl(4-(trifluoromethyl)phenyl)methylthio)propanoic acid | Ki | 50.0 [1] |
| 5-(2,5-Difluorophenyl)-N,N-dimethyl-3-phenyl-3,4-dihydropyrazole-2-carboxamide | IC50 | 84.0 [1] |
| 2-(Trifluoromethyl)-9H-carbazole | IC50 | 210.0 [1], 260.0 [2] |
| (5S)-5-(3-Aminopropyl)-3-(2,5-difluorophenyl)-N,N-dimethyl-5-phenyl-4H-pyrazole-1-carboxamide | IC50 | 1.9 [1], 2.0 [2] |
| (2r)-2-Amino-3-[(4-Chlorophenyl)-Diphenyl-Methyl]sulfanyl-Propanoic Acid | IC50 | 53.3 [1] |
| (2r)-2-Amino-3-[(4-Chlorophenyl)-Diphenyl-Methyl]sulfanyl-Propanoic Acid | Ki | 50.0 [1], 200.0 [2] |
| (2R)-2-Amino-3-[(2-methyl-1,1-diphenylpropyl)sulfanyl]propanoic acid | IC50 | 1152.6 [1] |
| (2R)-2-Amino-3-[(2-methyl-1,1-diphenylpropyl)sulfanyl]propanoic acid | Ki | 150.0 [1], 174.5 [2] |
| (2R)-2-Amino-3-{[(4-bromophenyl)diphenylmethyl]sulfanyl}propanoic acid | IC50 | 26.8 [1] |
| (2R)-2-Amino-3-{[(4-bromophenyl)diphenylmethyl]sulfanyl}propanoic acid | Ki | 50.0 [1], 250.0 [2] |
| 3-(2,5-Difluorophenyl)-N-methyl-5-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamide | IC50 | 3100.0 [1], 3140.0 [2] |
| 1-[(5S)-3-(2-Chlorophenyl)-5-(3-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one | IC50 | 450.0 [1] |
| (2R)-2-Amino-3-[(1,1-diphenylpentyl)sulfanyl]propanoic acid | IC50 | 318.8 [1] |
| (2R)-2-Amino-3-[(1,1-diphenylpentyl)sulfanyl]propanoic acid | Ki | 50.0 [1], 175.0 [2] |
| (5S)-5-(3-Aminopropyl)-3-(2,5-difluorophenyl)-N,N-dimethyl-5-phenyl-2H-pyrrole-1-carboxamide | IC50 | 2.2 [1], 23.0 [2] |
| (2r)-2-Amino-5-(3-Methylphenyl)-5,5-Diphenylpropanoic Acid | Ki | 6.4 [1], 7.1 [2], 10.2 [3] |
| 4-(4-Methylphenyl)-4,4-diphenylbutan-1-amine | Ki | 9.7 [1], 16.4 [2] |
| (5S)-5-[(3S)-3-Amino-4,4-difluorobutyl]-3-(2,5-difluorophenyl)-N,N-dimethyl-5-phenyl-2H-pyrrole-1-carboxamide | IC50 | 5.2 [1], 24.0 [2], 123.0 [3] |
| N-[2-[2-(2-Aminoethoxy)ethoxy]ethyl]-4-(3-hydroxyphenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxamide | IC50 | 3900.0 [1], 18300.0 [2], 22000.0 [3] |
| Gossypol | IC50 | 10800.0 [1], 25000.0 [2] |
| (S)-Monastrol | IC50 | 10000.0 [1] |
| Dimethylenastron | IC50 | 200.0 [1] |
| Litronesib | IC50 | 7.0 [1], 26.0 [2] |
| (4R)-4-(3-Hydroxyphenyl)-N,N,7,8-tetramethyl-3,4-dihydroisoquinoline-2(1H)-carboxamide | IC50 | 104.0 [1] |
| 2-Hydroxyethyl N-[(2S)-1-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydropyrrol-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate | IC50 | 7.4 [1] |
| N-(3-Aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-3-fluoro-4-methylbenzamide | Ki | 1.0 [1], 350.0 [2] |
| 2-(3-Fluoro-4-methoxyanilino)-1-[[2-(trifluoromethyl)phenyl]methyl]benzimidazole-5-carboxylic acid | IC50 | 458.8 [1], 2300.0 [2] |
| 1-(3-(2-Fluorophenyl)-5-phenyl-4,5-dihydropyrazol-1-yl)ethanone | IC50 | 3600.0 [1] |
| 1-[3-(2,5-Difluorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one | IC50 | 94.0 [1] |
| 1-(3-(3-Chlorophenyl)-5-phenyl-4,5-dihydropyrazol-1-yl)ethanone | IC50 | 9800.0 [1] |
| 3-(2,5-Difluoro-phenyl)-1-methanesulfonyl-5-phenyl-4,5-dihydro-1H-pyrazole | IC50 | 1800.0 [1] |
| 1-(3-(2-Chlorophenyl)-5-phenyl-4,5-dihydropyrazol-1-yl)ethanone | IC50 | 3600.0 [1] |
| Methyl (2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoate | IC50 | 5800.0 [1] |
| Methyl (2R)-2-amino-3-[(triphenylmethyl)sulfanyl]propanoate | Ki | 120.0 [1] |
| N-[4'-(Trifluoromethyl)-4-biphenylyl]sulfamide | Ki | 6.2 [1], 7.0 [2] |
| 2-Fluoro-4-[4-(sulfamoylamino)phenyl]-1-(trifluoromethyl)benzene | IC50 | 15.0 [1], 20.0 [2] |
| [4-[4-(Trifluoromethyl)phenyl]phenyl]urea | IC50 | 39.0 [1], 140.0 [2] |
| 1-[(3R,3Ar)-3-[3-(4-acetylpiperazin-1-yl)propyl]-8-fluoro-3-phenyl-3a,4-dihydropyrazolo[5,1-c][1,4]benzoxazin-2-yl]ethanone | IC50 | 1.6 [1] |
| Urea, [7-(trifluoromethyl)-9H-carbazol-3-yl]- | IC50 | 120.0 [1] |
| 2-{[(4-Methoxyphenyl)(diphenyl)methyl]sulfanyl}ethan-1-amine | IC50 | 136.0 [1] |
| 2-{[(4-Methoxyphenyl)(diphenyl)methyl]sulfanyl}ethan-1-amine | Ki | 21.5 [1] |
| N,N-Diethyl-5,5-dimethyl-2-(thiophene-2-carbonylamino)-6,7-dihydro-4H-1-benzothiophene-3-carboxamide | IC50 | 3100.0 [1] |
| 9H-Pyrido[3,4-b]indole, 7-(trifluoromethyl)- | IC50 | 52.0 [1] |
| (2S)-N-(1-Acetylpiperidin-4-yl)-4-(2,5-difluorophenyl)-N-methyl-2-phenyl-2,5-dihydropyrrole-1-carboxamide | IC50 | 50.0 [1] |
| (2S)-N-(3-Aminopropyl)-4-(2,5-difluorophenyl)-N-methyl-2-phenyl-2,5-dihydropyrrole-1-carboxamide | IC50 | 16.0 [1] |
| 3-Amino-1-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydropyrrol-1-yl]-2,2-dimethylpropan-1-one | IC50 | 5.2 [1] |
| (1S)-1-Cyclopropyl-2-[(2S)-4-(2,5-difluorophenyl)-2-phenyl-2,5-dihydro-1H-pyrrol-1-yl]-2-oxoethanol | IC50 | 11.0 [1] |
| 1-[(5S)-3-(2,5-Difluorophenyl)-5-(3-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]ethan-1-one | IC50 | 24.7 [1], 26.0 [2] |
| 7,8-Dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline | IC50 | 8230.0 [1], 8330.0 [2] |
| 2-Ethyl-7,8-dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline | IC50 | 25200.0 [1] |
| 2-(7,8-Dimethyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-2-yl)ethan-1-amine | IC50 | 2270.0 [1] |
| 4-(3-Hydroxyphenyl)-N,N,7,8-tetramethyl-3,4-dihydro-1H-isoquinoline-2-carboxamide | IC50 | 306.0 [1] |
| 7-Bromo-4-(3-hydroxyphenyl)-N,N-dimethyl-3,4-dihydro-1H-isoquinoline-2-carboxamide | IC50 | 808.0 [1] |
| 1-(3-(2,5-Difluorophenyl)-5-phenyl-4,5-dihydropyrazol-1-yl)ethanethione | IC50 | 250.0 [1] |
| 1-(3-(2,5-Difluorophenyl)-5-(thiophen-2-yl)-4,5-dihydropyrazol-1-yl)ethanone | IC50 | 1800.0 [1] |
| (2S)-1-[(2S)-4-(2,5-Difluorophenyl)-2-(3-hydroxyphenyl)-2,5-dihydropyrrol-1-yl]-2-hydroxy-3,3-dimethylbutan-1-one | IC50 | 1.3 [1] |
| (2S)-4-(2,5-Difluorophenyl)-N-(2-hydroxyethyl)-2-(3-hydroxyphenyl)-N-methyl-2,5-dihydropyrrole-1-carboxamide | IC50 | 4.0 [1] |
| (2S)-2-Amino-1-[(2S)-4-(2,5-difluorophenyl)-2-(3-hydroxyphenyl)-2,5-dihydropyrrol-1-yl]-3-methylbutan-1-one | IC50 | 1.2 [1] |
| (2S)-2-Amino-2-cyclopropyl-1-[(2S)-4-(2,5-difluorophenyl)-2-(3-hydroxyphenyl)-2,5-dihydropyrrol-1-yl]ethanone | IC50 | 0.5 [1] |
| 4-(3-Hydroxyphenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylic acid | IC50 | 32000.0 [1], 72200.0 [2] |
| CID 44435336 | IC50 | 11500.0 [1], 23000.0 [2] |
| 5H-Pyrido[4,3-b]indole, 7-(trifluoromethyl)- | IC50 | 95.0 [1] |
| (4s)-4-(3-Hydroxyphenyl)-7,7-Dimethyl-2-Thioxo-2,3,4,6,7,8-Hexahydroquinazolin-5(1h)-One | IC50 | 200.0 [1] |
| (2R)-2-Amino-3-[(4-cyclohexylphenyl)-diphenylmethyl]sulfanylpropanoic acid | IC50 | 1578.0 [1] |
| (2R)-2-Amino-3-[(4-cyclohexylphenyl)-diphenylmethyl]sulfanylpropanoic acid | Ki | 3263.7 [1] |
| (2R)-2-Amino-3-[diphenyl-(4-phenylphenyl)methyl]sulfanylpropanoic acid | IC50 | 1970.0 [1] |
| (2R)-2-Amino-3-[diphenyl-(4-phenylphenyl)methyl]sulfanylpropanoic acid | Ki | 1349.7 [1] |
| (2R)-2-Amino-3-[(4-tert-butylphenyl)-diphenylmethyl]sulfanylpropanoic acid | IC50 | 1244.0 [1] |
| (2R)-2-Amino-3-[(4-tert-butylphenyl)-diphenylmethyl]sulfanylpropanoic acid | Ki | 428.6 [1] |